| STUDY TYPE (EN) | LOCATION (EN) | COMPANY (EN) | BRANCH (EN) | INVESTIGATOR | PHASE (EN) | STUDY TITLE (EN) | STATUS (EN) | LINK (EN) |
|---|---|---|---|---|---|---|---|---|
| CLINICAL TRIAL | IZMIR MPH | ASTRAZENECA ILAC SAN.VE TIC.LTD.STI. | NEPHROLOGY | PROF DR ERHAN TATAR | PHASE 3 | A Double-Blind, Randomised, Placebo-Controlled, Multicentre Study Evaluating the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension | ONGOING | https://clinicaltrials.gov/study/NCT06344104 |
| CLINICAL TRIAL | IZMIR MPH | NOVARTIS SAGLIK GIDA VE TARIM URUNLERI SAN. VE TIC. A.S. | NEPHROLOGY | PROF DR ERHAN TATAR | PHASE 3 | A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Iptacopan (LNP023) in Idiopathic Immune-complex-mediated Membranoproliferative Glomerulonephritis (IC-MPGN) | ONGOING | https://clinicaltrials.gov/study/NCT05755386 |
| STUDY TYPE (EN) | LOCATION (EN) | COMPANY (EN) | BRANCH (EN) | INVESTIGATOR | PHASE (EN) | STUDY TITLE (EN) | STATUS (EN) | LINK (EN) |



